CSF2 and melanoma: In some settings, such as the melanoma tumor microenvironment, GM-CSF can enhance the formation of cross-presenting dendritic cells, improving the presentation of tumor antigens and increasing the quality of anti-tumor T cell responses; these effects can potentially work synergistically with checkpoint blockade.